ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+2.4%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$370M
AUM Growth
+$370M
(+12%)
Cap. Flow
+$91.4M
Cap. Flow
% of AUM
24.72%
Top 10 Holdings %
Top 10 Hldgs %
53.19%
Holding
85
New
33
Increased
12
Reduced
20
Closed
17
Top Buys
| 1 |
AstraZeneca
AZN
|
$18.9M |
| 2 |
Sanofi
SNY
|
$18.5M |
| 3 |
Labcorp
LH
|
$14.6M |
| 4 |
Cencora
COR
|
$12.4M |
| 5 |
Charles River Laboratories
CRL
|
$7M |
Top Sells
| 1 |
AbbVie
ABBV
|
$19.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
$12.5M |
| 3 |
Icon
ICLR
|
$12.2M |
| 4 |
Johnson & Johnson
JNJ
|
$9.46M |
| 5 |
Owens & Minor
OMI
|
$7.88M |
Sector Composition
| 1 | Healthcare | 80.71% |
| 2 | Industrials | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sanofi
SNY
$121B
| $21.3M | 5.13% | 424,490 +369,669 | +674% | +$18.5M |
|
|
2
Labcorp
LH
$23.1B
| $20.5M | 4.96% | 65,372 +46,543 | +247% | +$14.6M |
|
|
3
AstraZeneca
AZN
$248B
| $18.9M | 4.57% | +324,728 | New | +$18.9M |
|
4
SI-BONE Inc
SIBN
$719M
| $17M | 4.11% | 767,126 +295,912 | +63% | +$6.57M |
|
5
Humana
HUM
$36.5B
| $15.8M | 3.8% | 33,981 -10,041 | -23% | -$4.66M |
|
|
6
Cencora
COR
$56.5B
| $15.3M | 3.69% | 115,003 +93,573 | +437% | +$12.4M |
|
7
Hologic
HOLX
$14.9B
| $13.9M | 3.35% | 181,068 -19,051 | -10% | -$1.46M |
|
8
Tenet Healthcare
THC
$16.3B
| $12M | 2.9% | 146,929 -32,359 | -18% | -$2.64M |
|
9
Bio-Rad Laboratories Class A
BIO
$8.06B
| $11M | 2.65% | 14,539 -3,733 | -20% | -$2.82M |
|
10
Dentsply Sirona
XRAY
$2.85B
| $9.62M | 2.32% | 172,384 +111,764 | +184% | +$6.24M |
|
11
Becton Dickinson
BDX
$55.3B
| $8.66M | 2.09% | 34,452 +23,375 | +211% | +$5.88M |
|
12
Cigna
CI
$80.3B
| $8.42M | 2.03% | 36,646 +458 | +1% | +$105K |
|
|
SYNH
13
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $7.73M | 1.87% | 75,275 -17,486 | -19% | -$1.8M |
|
|
14
Johnson & Johnson
JNJ
$427B
| $7.32M | 1.77% | 42,762 -55,315 | -56% | -$9.46M |
|
|
15
Charles River Laboratories
CRL
$8.04B
| $7M | 1.69% | +18,586 | New | +$7M |
|
16
Cartesian Therapeutics
RNAC
$261M
| $6.92M | 1.67% | 2,123,526 +1,102,025 | +108% | +$3.59M |
|
17
Elutia
ELUT
$96.7M
| $6.78M | 1.64% | 1,075,640 +123,030 | +13% | +$775K |
|
18
Revvity
RVTY
$10.5B
| $5.94M | 1.43% | 29,543 +10,279 | +53% | +$2.07M |
|
19
Centene
CNC
$14.3B
| $5.84M | 1.41% | +70,809 | New | +$5.84M |
|
20
SPDR S&P Biotech ETF
XBI
$5.07B
| $5.48M | 1.32% | +48,906 | New | +$5.48M |
|
|
OCDX
21
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $5.25M | 1.27% | +245,484 | New | +$5.25M |
|
|
RCM
22
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.24M | 1.26% | 205,400 -77,511 | -27% | -$1.98M |
|
23
Ocular Therapeutix
OCUL
$2.12B
| $5M | 1.21% | 717,143 +106,742 | +17% | +$744K |
|
24
Avantor
AVTR
$9.18B
| $4.51M | 1.09% | 106,996 -54,967 | -34% | -$2.32M |
|
25
Haemonetics
HAE
$2.63B
| $3.92M | 0.95% | +73,914 | New | +$3.92M |
|